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Human intrinsic factor was purified 1430-fold from gastric juice with a yield of 75% using two steps: labile 
ligand affinity chromatography and high-performance ion-exchange chromatography. Intrinsic factor pre- 
cipitated in the presence of specific autoantibodies and 15% sodium sulfate, had an estimated IV, of 59000 
in 5% SDS electrophoresis and could bind to the specific ileal receptor in vitro. Its carbohydrate composi- 
tion could be related to N-lactosaminic and 0-glycosidic chains. High-performance ion-exchange chromato- 
graphy was a mild, rapid and effkient procedure to separate completely intrinsic factor from haptocorrin 
(another glycoprotein of gastric juice which binds cobalamin) and from other contaminating proteins. 
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1. INTRODUCTION 
In man, the intraluminal transport of cobalamin 
(vitamin B12) involves 2 glycoproteins, intrinsic 
factor (IF) and haptocorrin (Hc, also named R 
protein or R binder). These two binders are present 
in gastric juice. IF is a permease which promotes 
the uptake of dietary cobalamin (Cbl) in the distal 
ileum via specific receptors. The binding of 
cobalamin to IF is very specific while haptocorrin 
binds numerous cobalamin analogues (e.g., 
cobinamide). 
Affinity chromatography is mostly used in the 
purification of IF as an initial or as a single step, 
with the exception of a recent work which used im- 
munoadsorption to anti-IF autoantibodies [ 11. 
This type of affinity chromatography uses 
cobalamin bound to amino-Sepharose by a 
temperature-sensitive Co-N or a light-sensitive Co- 
C linkage [2,3]. In other procedures, a cobalamin 
derivative is covalently coupled to amino- 
substituted Sepharose [4,5]. In these cases, the 
desorption is provided by a denaturation of the 
Cbl binder by agents such as guanidine 
hydrochloride which may modify the structure and 
composition of the molecule [6,7]. Another step of 
the purification is needed to separate IF from hap- 
tocorrin and other proteic material. Several pro- 
cedures are used, e.g., gel filtration [2] or affinity 
chromatography with immobilized corrinoids [8]. 
Here, we have purified intrinsic factor from 
human gastric juice using two steps: labile ligand 
affinity chromatography and high-performance 
ion-exchange chromatography (HPIEC). 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Crystalline hydroxocobalamin (OH-Cbl) was 
obtained from Sigma, St Louis, crystalline 
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cobinamide from Calbiochem, La Jolla and 
cyano[“Co]cobalamin (spec. act. 220 ,&i/pg) 
from the Radiochemical Centre, Amersham. Ac- 
tivated AH-Sepharose-4B was purchased from 
Pharmacia, Uppsala, Sweden. All other reagents 
were obtained as described previously [9]. 
2.2. Gastric juice 
Normal human gastric juice was aspirated, after 
pentagastrin stimulation, by naso-gastric tube. The 
pepsin activity was reduced by consecutive pH ad- 
justment to 10.0 and 7.0 as described [lo]. The 
pooled gastric juice was stored at -20°C. It was 
filtered through a Celite layer in a Buchner funnel 
followed by centrifugation at 17000 x g for 
30 min. Unsaturated Cbl binding capacities of IF 
and haptocorrin were determined using the 
methods of Gottlieb et al. [l l] and Begley and 
Trachtenberg [12] with hemoglobin-coated char- 
coal and cobinamide. Haptocorrin was saturated 
by incubation of gastric juice with cobinamide 
(400-fold the cobalamin binding capacity). Gastric 
juice was mixed with 0.1 M Tris-HCl buffer (pH 
8.0) (10% of the total volume). 
2.3. Affihity chromatography 
Hydroxocobalamin was coupled to activated 
AH-Sepharose4B by a thermolabile Co-N linkage 
according to the method of Next [2]. Hy- 
droxo[57Co]cobalamin (OH-[57Co]Cbl) in 0.1 M 
NaHCO3 was prepared from cyano[57Co]cobal- 
amin by light exposure in 8 mM HCl. 4 pmol OH- 
Cbl and 13 pmol OH-[“Co]Cbl were incubated 
with 4 g Swollen AH-Sepharose4B in 0.1 M 
NaHCO3 (pH 8.2) containing 0.5 M NaCl at 4°C 
for 24 h under rotative agitation and protection 
from light. The suspension was subsequently 
poured onto a column and washed with 500 ml of 
0.1 M NaHCoJ (pH 8.2) containing 0.5 M NaCl, 
500 ml of 0.5 M NaCl and 500 ml of 0.02 M Tris- 
HCl buffer (pH 8.0). The coupling efficiencies of 
OH-Cbl and OH-[“Co]Cbl, determined using 
spectrophotometry and y-ray counting (Packard 
Autogamma, model 4780), were about 20 and 
14%, respectively. After the gastric juice was ap- 
plied to the column, the gel was washed successive- 
ly with 250 ml of 0.02 M Tris-HCl buffer (pH 8.2) 
containing 0.5 M NaCl and 250 ml of 0.02 M Tris- 
HCl buffer (pH 8.4). The total amount of IF 
coupled to the unsolubilized Cbl was estimated 
from determination of unsaturated cobalamin 
binding capacity of gastric juice before and after 
elution. After incubation of the column at 37°C 
for 20 h, the cobalamin intrinsic factor complexes 
were removed by washing the column with 20 ml 
of 0.02 M Tris-HCl buffer (pH 8.4) or 0.05 M 
sodium phosphate buffer (pH 7.4) at room temper- 
ature. 
2.4. High-performance ion-exchange chromatog- 
raphy 
HPIEC was carried out with an analytical 
HPLC system (Waters Associates, Milford, USA). 
The sample was dialyzed and concentrated up to 
2 ml by ultrafiltration using a YM-10 Diaflo mem- 
brane (Amicon, USA) and poured onto an anionic 
exchange column (Mono Q, Pharmacia). The 
mobile phase was 0.02 M Tris-HCl buffer (pH 8.4) 
with a O-100% NaCl gradient at a flow rate of 
1.0 ml.min-‘. The proteins and the cobalamin 
binders were detected by spectrophotometry at 
280 nm and radioactivity counting, respectively. 
The effluent was collected in 0.2-ml fractions (frac 
300, Pharmacia). 
2.5. Gel filtration 
Part of the sample obtained from affinity 
chromatography was filtered through a Sephadex 
G-200 column (2.5 x 90 cm) in 0.05 M sodium 
phosphate buffer (pH 7.4) containing 0.15 M 
NaCl and 3 mmol/l NaNs according to the method 
of Next [2]. 
2.6. Electrophoresis 
Polyacrylamide disc gel electrophoresis was car- 
ried out according to Fairbanks et al. [ 131. The 
sample contained 20 pg proteins and 10% sucrose 
(w/v) in a total volume of 40~1. The gels were 
stained for protein with Coomassie brilliant blue. 
The M, of IF was estimated in 5% SDS- 
polyacrylamide electrophoresis using lactalbumin, 
soybean trypsin inhibitor, ovalbumin, bovine 
serum albumin and phosphorylase b as reference 
molecules. 
2.7. Amino acid and carbohydrate analysis 
A part of the sample obtained from HPIEC was 
dialyzed, concentrated on a YM-10 ultrafiltration 
membrane and lyophilized for amino acid and car- 
bohydrate analysis. The amino acid content of IF 
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was determined after hydrolysis of the sample 
(0.17-0.25 mg) in a Beckman amino acid analyzer. 
The molar carbohydrate composition of the 
glycoprotein was determined according to the 
method of Zanetta et al. [14] modified as follows: 
150 pg glycoprotein (about 20 pg carbohydrates) 
was subjected to acid methanolysis in 1 ml MeOH 
containing 0.5 M HCl for 24 h at 80°C. The sam- 
ple was cooled to room temperature and the 
methanolysate was extracted twice with 1 ml hex- 
ane. The upper phases containing mostly amino 
acids were discarded and the lower phases were 
concentrated under a nitrogen flow. The residue 
was treated with 10~1 of dichloromethane and 
10 ,ul of trifluoroacetic anhydride for 12 h at room 
temperature. The carbohydrate derivatives were 
identified by gas chromatography. 
2.8. Activity of IF 
The immunoreactivity of the purified IF- 
[“Co]Cbl complex was tested by incubating the 
sample with a pernicious anaemia serum rich in 
binding-type anti-IF autoantibodies and by 
precipitating the immunocomplexes in 15% (w/v) 
sodium sulfate. A sample of the purified IF- 
[“Co]Cbl was incubated with the receptor extract 
prepared from pig small intestine as described 
earlier [15,16]. Pig IF-receptor is known to react 
with human IF. The incubation was performed in 
the presence of 0.1 mg CaClz (in 2 ml) or 5 pmol/l 
of EDTA. Each incubation mixture was then run 
through a Sephadex G-200 column (2.5 x 90 cm) 
in 0.1 M Tris-HCI buffer (pH 7.5) containing 
0.15 mol/l NaCl, 0.01% merthiolate and 0.05% 
Triton X-100. 
3. RESULTS 
IF has been purified 1430-fold with a yield of 
75% (table 1). It represented about 10% of the 
total unsaturated cobalamin binding capacity of 
gastric juice. 85% of the unsaturated cobalamin 
binding capacity of the treated gastric juice was 
immobilized onto the affinity column. Only some 
traces of radioactivity were found in the gel after 
its thermosensitive desorption. In HPIEC, the 
single collected radioactive peak was also the first 
eluted peak detected at 280 nm (fig.1). It cor- 
responded to saturated Cbl binders. Acidic pro- 
teins devoid of Cbl binding capacity were removed 
at a higher ionic strength. In another experiment, 
the use of guanidine hydrochloride during the 
desorption of the affinity column did not modify 
the liberation of these proteins. The radioactive 
peak collected from HPIEC was desalted and con- 
centrated by ultrafiltration. The saturated Cbl 
binder presented the characteristic UV absorption 
spectrum of an IF-Cbl complex [5,18]. The 
purified IF moved as a single protein band in 
polyacrylamide gel electrophoresis and SDS- 
polyacrylamide gel electrophoresis. In the latter, 
the migration corresponded to an estimated M, of 
about 59000 (fig.2). The amino acid composition 
of the molecule was similar to those previously 
determined [5,18] (table 2). The carbohydrates ex- 
tracted from the sample of purified IF correspond- 
ed to 14.2% of the molecule. The carbohydrate 
content of the purified IF is indicated in table 2. 
When IF was incubated with type II anti-IF au- 
toantibodies, more than 98% of the [“Co]Cbl-IF 
precipitated in the presence of 15% sodium sulfate 
Table 1 
Purification of human intrinsic factor (IF) 
Volume 
(ml) 
IF-Cbl 
binding 
capacity 
(nmol) 
Protein 
content 
(mg) 
Specific Purification Yield 
activity factor (0700) 
(nmol/mg) 
Human gastric juice 
Affinity chromatography 
on Cbl Sepharose 
HPIEC 
1450 48.1 3045 0.0158 _ - 
17 40.6a 15.4 2.6 164 83.2 
4.5 36.1a 1.8 22.6 1430 75.0 
a Determined from absorbance at 360 nm [17] 
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Fig.1. Elution profile of the affinity chromatography 
eluate (500 ~1) on HPIEC (column Mono Q). The mobile 
phase was 0.02 M Tris-HCl buffer (pH 8.4) with a 
gradient of O-l M NaCl in 15 ml. Flow rate 1 ml+h-r, 
detection by absorbance at 280 nm (-) and 
radioactivity of [57Co]Cbl. When the gastric juice was 
previously incubated with cobinamide, a single 
radioactive peak was detected with a retention time of 
12.2 (-. -) corresponding to intrinsic factor. When 
cobinamide was not added, Hc was also detected with a 
retention time of 16.1 (...). 
(w/v) corresponding to the formation of a specific 
immune complex. The IF-[“Co]Cbl complex 
bound to the ileal specific receptor in the presence 
of CaClz because the filtration of the incubation 
mixture through a Sephadex G-200 column showed 
the elution of the complex in the void volume frac- 
tions. In the control experiment in the presence of 
EDTA the receptor complex was not able to form, 
since no peak emerged in the void volume of the 
gel filtration. When part of the sample of semi- 
purified IF obtained after desorption of the affini- 
ty gel was filtered through a Sephadex G-200 col- 
umn, a single symmetrical radioactive peak was 
collected, corresponding to IF-[57Co]Cbl. This 
peak had an AX&&~ ratio of about 3.5. This 
high ratio can be explained by the presence of some 
contaminating protein material devoid of Cbl 
binding capacity. In other purification ex- 
periments, we obtained a lower ratio, which could 
be explained by differences in the initial protein 
composition of gastric juice. 
Fig.2. SDS-polyacrylamide gel electrophoresis of 20 pg 
human intrinsic factor. A single band was identified with 
an Rf of 0.23 corresponding to an M, of 59000. 
4. DISCUSSION 
Several authors have purified unsaturated Cbl 
binders using elution of the affinity column with 
guanidine hydrochloride [5,6]. This procedure in- 
duces a strong denaturation of the proteins [6] 
even if it is carried out in presence of free 
cobalamin. Moreover, it is not certain that the 
changes of the molecule are completely reversed 
during subsequent dialysis. However, unsaturated 
IF can be separated from Hc in a second step using 
another affinity chromatography elution. Labile 
ligand affinity chromatography is a very mild pro- 
cedure. The semi-purified molecule is then 
saturated with OH-Cbl, and it is therefore impossi- 
ble to achieve the purification using affinity 
chromatography in a second step. Gel filtration 
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Table 2 
Amino acid content (residues per mol) of human intrinsic factor 
Amino acid 
Lysine 
Histidine 
Arginine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Ileucine 
Leucine 
Tyrosine 
Phenylalanine 
Methionine 
Half-cystine 
Tryptophan 
Present Allen and Next et al. Christensen 
study Mehlman IS] I181 et al. [4] 
18 20 19 16 
5 5 4 5 
6 6 5 6 
39 38 39 37 
24 24 26 26 
31 30 36 33 
36 35 33 36 
23 22 21 32 
23 20 20 24 
24 23 24 23 
23 22 24 24 
20 22 23 20 
30 34 35 30 
9 9 10 10 
9 9 10 10 
10 10 11 8 
5 6 6 12 
6 6 3 - 
Total 344 342 349 351 
has been previously used for this purpose [2]. In 
our experience, this technique does not always 
remove the proteins present in the IF sample after 
the affinity c~omatography. These proteins could 
be adsorbed to the arm of the affinity gel by 
unspecific interactions during the elution of gastric 
juice. Desorption of the gel with variable ionic 
strength buffers or with agents as guanidine 
hydrochloride does not modify the removal of 
these proteins. They can be removed easily from IF 
using HPIEC (fig.1). A second problem in the 
purification of IF is to eliminate completely Hc in 
the final sample. Here, we saturated the un- 
saturated cobalamin binding capacity of Hc in 
gastric juice using cobinamide. In another experi- 
ment, we separated partially degraded and 
undegraded Hc from IF in the HPIEC step of the 
purification. Hc is more acidic than IF and is 
eluted at a higher ionic strength (fig. 1). Each peak 
was identified by specific immunoprecipitation in 
15% sodium sulfate. The purified IF had similar 
physicochemic~ characteristics to those previously 
described in respect o its electrophoretic mobility, 
UV absorption spectra and amino acid composi- 
18 
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tion. Gel filtration has also been employed by 
several authors to separate Hc from IF in a final 
step of purification [2]. In our experience, gel 
filtration cannot separate IF from partially degrad- 
ed Hc which is present in the gastric juice, since 
both molecules have similar molecular masses [191. 
The amino acid composition of IF was similar to 
those previously determined [4,5,18] whereas 
significant differences were observed in the car- 
Table 3 
Carbohydrate content of human intrinsic factor 
mol per 3 mol mannose” 
Fucose 3.22 (1.75) 
Galactose 6.06 (1.50) 
Mannose 3.00 (3.00) 
Glucose 1.10 (0.00) 
N-Acetylgalactosamine 2.71 (0.75) 
~-Aceiylglucosamine 5.21 (1.50) 
Sialic acid 1.99 (0.75) 
a Values in parentheses calculated from [5] 
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bohydrate composition, particularly concerning 
the number of mannose residues (table 3). The car- 
bohydrate content of IF, according to several 
authors [2,5], corresponded to a glycoprotein with 
polymannosidic chains [20]. With regard to our 
results, it may be assumed that IF contains mainly 
N-lactosaminic-type carbohydrate chains [20]. 
Moreover, the presence of Gal-Nat residues in- 
dicated the presence of 0-glycosidic carbohydrate 
chains on the molecule. Another predominant 
feature is the high content of fucose, in com- 
parison to sialic acid. This observation may be 
related to the biosynthetic origin of the glycopro- 
tein. Fucose may also be related to a structural 
recognition for the final destination of the 
glycoprotein. It must be noted that gels such as 
Sephadex or Sepharose in the purification steps 
may dissociate glucose which becomes a contami- 
nant in gas chromatography. Glucose can be 
detected as mannose residue since it may have a 
very similar retention time in gas chromatography. 
In conclusion, the sequence of labile ligand af- 
finity chromatography and HPIEC seems to be an 
efficient and mild procedure to purified human IF 
since (i) the purified molecule is not treated using 
denaturing agents, and (ii) the second step can be 
completed very quickly and completely removes 
Hc and other contaminating acidic proteins from 
IF. 
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